Rapid Antibody Testing for SARS‐CoV‐2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed Infections
Open Access
- 3 June 2020
- journal article
- letter
- Published by Wiley in HemaSphere
- Vol. 4 (3), e408
- https://doi.org/10.1097/hs9.0000000000000408
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology, 2020
- Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19The New England Journal of Medicine, 2020
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19The New England Journal of Medicine, 2020
- Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front LineThe New England Journal of Medicine, 2020
- Handling the COVID-19 pandemic in the oncological settingThe Lancet Haematology, 2020
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)Science, 2020
- Caring for patients with cancer in the COVID-19 eraNature Medicine, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Public awareness, news promptness and the measles outbreak in Hong Kong from March to April, 2019Infectious Diseases, 2020